The University of Southampton
SUSSED News

Take part in university-led clinical research

The NIHR Southampton Clinical Research Facility (CRF) is delivered in a longstanding partnership between the University and University Hospital Southampton NHS Foundation Trust.  

There are several opportunities this month for staff and their families to take part in ground-breaking clinical research studies that will improve treatments and care. 

Picture of the Southampton Centre for Biomedical Research.

Needleless COVID-19 vaccine 

Professor Saul Faust is leading a first-in-human, needle-less vaccine study that is designed to protect against multiple coronavirus variants.  

We are looking for people who are: 

  • aged 18-50 in good health 
  • immunised with 2 or 3 doses of COVID-19 vaccine 
  • able to attend up to 11 visits 
  • have not tested positive for COVID-19 in the last 180 days 

Contact [email protected] for more information. Payment of up to £1,005 will be provided. 

Sirona weight loss treatment 

Are you aged 18-65 with a BMI between 30 and 40?  

The Sirona trial is testing a new product designed to aid weight loss by reducing hunger. It takes three months, with appointments in Southampton and an MRI in Oxford and nurse and dietetic support. Compensation of up to £1,000 will be provided. 

Volunteers need to be healthy, not on long-term treatments and not had weight loss surgery. 

If you are interested in taking part, please email [email protected]. 

Antiviral trial for COVID-19 

The PANORAMIC trial is looking for people who have tested positive for COVID-19 and are within five days of the onset of symptoms. The national trial, co-led by Professor Paul Little, is investigating the effectiveness of new antiviral treatments for COVID-19. 

Volunteers need to be aged 50 and over, or between 18 to 49 years with underlying health conditions which make them clinically vulnerable. 

Find out more and sign up through the trial website: www.panoramictrial.org 

CCHF vaccine study 

We are currently looking for healthy volunteers aged between 18 – 45 years to take part in our Crimean-Congo Haemorrhagic Fever (CCHF) vaccine study. Participation in the study will last for approximately 12 months, and volunteers will be compensated up to £905 for their time and travel. 

Contact [email protected] or call 0238 120 4989 for further details. 

Footer block - blue

 
Share this post Facebook Google+ Twitter Weibo
Powered by Fruition